NCT03190421 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

KASS EH
Asymptomatic infections of the urinary tract. Trans Assoc Am Physicians. 1956;69:56-64.
Maskell R, Pead L, Allen J
The puzzle of "urethral syndrome": a possible answer? Lancet. 1979 May 19;1(8125):1058-9.
Yuan S, Cohen DB, Ravel J, Abdo Z, Forney LJ
Evaluation of methods for the extraction and purification of DNA from the human microbiome. PLoS One. 2012;7(3):e33865. doi: 10.1371/journal.pone.0033865. Epub 2012 Mar 23.

The Use of Expanded Quantitative Urinary Culture (EQUC) Versus Standard Culture (SUC) Techniques in the Clinical Care of Women With Symptoms of Urinary Tract Infections.

Details for clinical trial NCT03190421

Clinical trial NCT03190421 - References